x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

business

All Episodes

22:05

Episode 42: Parsing Bristol-Myers-Celgene, grousing...

The Readout Loud ·

2019/01/03

Are megamergers bad for business? Is it time for biotech's biggest gathering to find a new home? And can a "need" be anything but "unmet"?

en

26:38

Episode 41: Watson's latest stumble, a glimpse into...

The Readout Loud ·

2018/12/20

What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?

en

23:16

Episode 40: Gilead’s new boss, the year that was, and...

The Readout Loud ·

2018/12/13

Is Gilead Sciences entering a bold new era? What even happened in 2018? And how useful is a genetic credit score?

en

22:45

Episode 39: Using the word 'cure,' an FDA loophole, &...

The Readout Loud ·

2018/12/06

Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019?

en

23:56

Episode 38: Your guide to the #CRISPRbabies controversy

The Readout Loud ·

2018/11/29

What does it mean to edit a person? Has science run afoul of basic ethics? And what's the time difference to Hong Kong?

en

26:17

Episode 37: The biggest-ever IPO, drug prices rising...

The Readout Loud ·

2018/11/15

Can unicorns float? Is a hot dog a sandwich? And how are drug companies like gas stations?

en

22:46

Episode 36: What the midterms mean, a golden age on...

The Readout Loud ·

2018/11/08

Is pharma in for a swarm of subpoenas? Are we running out of ideas in oncology? And can a drug possibly be worth $4 million a dose?

en

26:12

Episode 35: Biotech's October slump, the precise cost...

The Readout Loud ·

2018/11/01

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?

en

21:35

Episode 34: Pharma at the ballot box, the latest...

The Readout Loud ·

2018/10/25

Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?

en

24:33

Episode 33: Drug prices on TV, immortal blockbusters,...

The Readout Loud ·

2018/10/18

Are prescription drugs like new cars? Is pharma's grand bargain a sham? And who keeps your DNA safe?

en

22:47

Episode 32: Fake friends at the FDA, cancer...

The Readout Loud ·

2018/10/11

Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?

en

23:42

Episode 31: Nobel snubs, millenial founders, and a...

The Readout Loud ·

2018/10/04

Did the Nobel Prizes go to the right scientists? Why is there so much disdain for biotech's millenial entrepreneurs? And do journalists have a good taste in '80s music?

en

25:13

Episode 30: A fish oil epiphany, VC monopolies and...

The Readout Loud ·

2018/09/27

Was everyone wrong about fish oil? Is venture capital a cartel? And what's with all those ketamine clinics?

en

24:38

Episode 29: A Hong Kong heat-check, a $20 million...

The Readout Loud ·

2018/09/20

Is a biotech bubble inflating in China? Do the feds coddle CEOs? And why don't clinical trials look like America?

en

22:57

Episode 28: Founders' funds, doctors' disclosures,...

The Readout Loud ·

2018/09/13

Is biotech too founder-friendly? Is honesty overrated? And how do you tell a good beep from a bad one?

en

26:08

Episode 27: Live from Boston!

The Readout Loud ·

2018/09/06

Should genome editors be worried? Has 2018 been a bummer? And are voters ready to love Big Pharma? We discuss this and more on a special live episode from the BioPharm America conference in Boston.

en

17:57

Episode 26: FDA shows its teeth, biotech fish oil...

The Readout Loud ·

2018/08/30

Is the FDA as lenient as everyone thinks? Can fish oil be a multibillion-dollar drug? And why aren't there better treatments for brain cancer?

en

21:48

Episode 25: A genome-editing first, Trump on Wall...

The Readout Loud ·

2018/08/23

Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens?

en

23:52

Episode 24: A lesson in startup jargon, pharma's bare...

The Readout Loud ·

2018/08/16

How much is a shot at curing cancer worth? Where are all the drugs for late-stage Alzheimer's disease? And what on Earth is an "oversubscribed Series A round"?

en

21:09

Episode 23: Congressional insider trading, PETA and...

The Readout Loud ·

2018/08/09

Can insider trading charges derail political campaigns? Should you trust a fund manager over a doctor? And how many rats would you trade for a cow?

en

383 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...